Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

STudy of Real World vaccinE Effectiveness of maTernal RSVpreF vaccinatiON Against Respiratory Syncytial Virus (RSV) in Hospitalised Infants in Australia

NCT07122661 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT07122661
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07122661 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
STudy of Real World vaccinE Effectiveness of maTernal RSVpreF vaccinatiON Against Respiratory Syncytial Virus (RSV) in Hospitalised Infants in Australia
Lead sponsor
Pfizer
Phase
Observational
Overall status
Active, not recruiting
Start date
August 11, 2025
Completion date
April 30, 2027
Enrollment
1 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute respiratory illness (ari), lower respiratory tract disease, respiratory syncytial virus, respiratory syncytial virus (rsv), respiratory tract diseases